| Biotechnology Industry | Healthcare Sector | Mr. Steen Dannemann Andersen CEO | XFRA Exchange | GB00BLNBFR86 ISIN |
| United Kingdom Country | 8 Employees | - Last Dividend | - Last Split | - IPO Date |
ProBiotix Health Plc is a pioneering company that focuses on the development of probiotics aimed at combating cardiovascular diseases and other lifestyle-related conditions. Initially established as ProBiotix Health Limited, the company transitioned to its current name, ProBiotix Health Plc, in February 2022, marking a significant phase in its evolution. The inception of the company took place in 2021, and it has since then established its headquarters in Wakefield, the United Kingdom. Operating as a subsidiary of OptiBiotix Health Plc, ProBiotix Health Plc is positioned at the forefront of leveraging the potential of probiotics to enhance cardiac health and address various lifestyle diseases, leveraging scientific advances to pioneer health solutions in the probiotic sector.
ProBiotix Health Plc offers a range of products and services designed to leverage the health benefits of probiotics, specifically targeting lifestyle-related diseases such as cardiovascular conditions. Below is an overview of their key offerings: